1,5-Anhydroglucitol and Time in Range as Complementary Markers for Diabetic Retinopathy in Type 2 Diabetes.

Key Points

• The study aims to explore the relationship between serum 1,5-AG and time in range in assessing diabetic retinopathy risk for type 2 diabetes patients.
• Analyzed serum 1,5-AG levels
• Evaluated time in range (TIR) as a relevant metric
• Examined the prevalence of diabetic retinopathy in patients
• Higher serum 1,5-AG levels were associated with increased prevalence of diabetic retinopathy.
• Patients with a time in range of 80% or more showed additional risk indicators for diabetic retinopathy.

Abstract